Wednesday, October 15, 2025
2:00PM – 3:00PM ET
Please note this TeleECHO program is 2:00PM Eastern, 1:00PM Central, 12:00PM Mountain and 11:00AM Pacific.
PRESENTING FACULTY
 |
Elana Jaye Bernstein, MD, MSc Florence Irving Associate Professor of Medicine Director, Columbia Scleroderma Center Director of Research, Division of Rheumatology and Clinical Immunology Columbia University Vagelos College of Physicians and Surgeons New York, New York |
PROGRAM OVERVIEW
This program is designed to provide a comprehensive overview of fibrosing interstitial lung disease (F-ILD), focusing on its key characteristics and diverse subtypes. It will explore the pathophysiology, clinical presentation, and disease burden of F-ILD. The program will also address strategies to improve diagnostic accuracy and evaluate the efficacy, safety, and tolerability of new and emerging treatment options. Additionally, it will highlight the critical role of rheumatologists in the effective management of F-ILD.
TARGET AUDIENCE
This activity is designed to meet the educational needs of rheumatologists in community practices and their clinical teams.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Describe key characteristics of F-ILDs (eg, IPF, PPF, and SARD-ILD) including pathophysiology, clinical presentation, and burdens
- Incorporate strategies for improving diagnostic accuracy of F-ILDs including IPF, PPF, and SARD-ILD in community practice
- Outline efficacy, safety, and tolerability results from clinical trials evaluating new and emerging treatment options for F-ILDs including IPF, PPF, and SARD-ILD
- Evaluate the roles for rheumatologists in community practice on multidisciplinary teams essential for comprehensive management of F-ILDs including IPF, PPF, and SARD-ILD
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hours.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, dietary, physical, etc). Please contact Med Learning Group prior to participating at [email protected]
